Hepatitis C, the top reason for a liver transplant, could be considered a ‘rare disease’ by 2030

Pfizer’s Xeljanz rheumatoid arthritis drug meets endpoints in ulcerative colitis trials
June 9, 2016
Men With Breast Cancer Can Miss Out On Help
June 10, 2016
Show all

Hepatitis C, the top reason for a liver transplant, could be considered a ‘rare disease’ by 2030

Advances in hepatitis C treatment could make this disease “rare” by 2030.

Nationwide, there are hundreds of thousands on various waiting lists for organ transplants. In the St. Louis area, there 200-250 patients waiting for a liver transplant and 1,300 patients waiting for a kidney transplant.

The guests also discussed the importance of organ donation, signing up to donate while living and also after death. Here’s who joined us for the discussion:

Read Full Article: Hepatitis C, the top reason for a liver transplant, could be considered a ‘rare disease’ by 2030 | St. Louis Public Radio

Read Full Article: Hepatitis C, the top reason for a liver transplant, could be considered a ‘rare disease’ by 2030 | St. Louis Public Radio

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.